FBIO
Fortress Biotech Inc
NASDAQ: FBIO · HEALTHCARE · BIOTECHNOLOGY
$1.99
-1.00% today
Updated 2026-11-12
Market cap
$64.37M
P/E ratio
0.70
P/S ratio
0.94x
EPS (TTM)
$2.76
Dividend yield
—
52W range
$2 – $5
Volume
0.2M
Fortress Biotech Inc (FBIO) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$1.99
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$13.57
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 0.70x (capped 25x) · Margin: 163.30%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.